Literature DB >> 18827979

The effects on cell growth and chemosensitivity by livin RNAi in non-small cell lung cancer.

Dong Yuan1, Liqun Liu, Huaming Xu, Dayong Gu.   

Abstract

Livin is highly expressed in most tumor tissues and could inhibit the tumor cells apoptosis. Knockdown of endogenous livin expression in non-small cell lung cancer (NSCLC) cells could inhibit cell growth. But it is still unclear if knockdown of endogenous livin expression combined with conventional chemotherapy could play a positive role in NSCLC treatment. In this article, the efficient RNA interferences (RNAi) of livin were constructed, and then we transfected them into A549 cells and 103H cells to study their influence on cell cycle and apoptosis index. At last, we detected the cell's sensitivity to conventional chemotherapeutic drugs after knockdown endogenous livin expression in A549 cells and 103H cells. Our results showed that knockdown livin expression could inhibit cell growth and induce apoptosis in A549 cells and 103H cells. A549 cells and 103H cells had an increased chemosensitivity to adriamycin and cisplatin after transfection of livin RNAi constructs. The results indicated that cell cycle redistribution and increased apoptosis index after knockdown livin expression might provide the main explanation for the enhanced chemosensitivity. Proper combination of livin RNAi and some conventional chemotherapeutic drugs may entail potential benefits in the treatment of NSCLC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18827979     DOI: 10.1007/s11010-008-9915-1

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  27 in total

1.  Growth suppression of human ovarian carcinoma OV-MZ-2a and OV-MZ-32 cells mediated by gene transfer of wild-type p53 enhanced by chemotherapy in vitro.

Authors:  Q Wu; R Kreienberg; I B Runnebaum
Journal:  J Cancer Res Clin Oncol       Date:  2000-03       Impact factor: 4.553

2.  Detection of autoantibodies to livin and survivin in Sera from lung cancer patients.

Authors:  Atsuhito Yagihashi; Koichi Asanuma; Daisuke Kobayashi; Naoki Tsuji; Yasuharu Shijubo; Shosaku Abe; Yoshihiko Hirohashi; Toshihiko Torigoe; Noriyuki Sato; Naoki Watanabe
Journal:  Lung Cancer       Date:  2005-01-08       Impact factor: 5.705

3.  Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin.

Authors:  Piyali Dasgupta; Rebecca Kinkade; Bharat Joshi; Christina Decook; Eric Haura; Srikumar Chellappan
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-06       Impact factor: 11.205

4.  Expression of the IAP protein family is dysregulated in pancreatic cancer cells and is important for resistance to chemotherapy.

Authors:  Rita Bayer Lopes; Rathi Gangeswaran; Iain A McNeish; Yaohe Wang; Nick R Lemoine
Journal:  Int J Cancer       Date:  2007-06-01       Impact factor: 7.396

5.  [Influence of survivin gene repression by RNA interference on the radiosensitivity and chemosensitivity to cisplatin of cervical cancer cell HeLa].

Authors:  Hui Song; Xiao-yan Xin; Feng Xiao; De-tang Wang; Xing Han; Hui-ling Guo
Journal:  Zhonghua Fu Chan Ke Za Zhi       Date:  2006-08

6.  RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells.

Authors:  Jenn-Yah Yu; Stacy L DeRuiter; David L Turner
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-23       Impact factor: 11.205

7.  Caspase-mediated cleavage converts Livin from an antiapoptotic to a proapoptotic factor: implications for drug-resistant melanoma.

Authors:  Boaz Nachmias; Yaqoub Ashhab; Vered Bucholtz; Olga Drize; Luna Kadouri; Michal Lotem; Tamar Peretz; Ofer Mandelboim; Dina Ben-Yehuda
Journal:  Cancer Res       Date:  2003-10-01       Impact factor: 12.701

8.  Adjuvant therapy with small hairpin RNA interference prevents non-small cell lung cancer metastasis development in mice.

Authors:  Etmar Bulk; Antje Hascher; Ruediger Liersch; Rolf M Mesters; Sven Diederichs; Bülent Sargin; Volker Gerke; Marc Hotfilder; Josef Vormoor; Wolfgang E Berdel; Hubert Serve; Carsten Müller-Tidow
Journal:  Cancer Res       Date:  2008-03-15       Impact factor: 12.701

9.  Induction of apoptosis in tumor cells by siRNA-mediated silencing of the livin/ML-IAP/KIAP gene.

Authors:  Irena Crnkovic-Mertens; Felix Hoppe-Seyler; Karin Butz
Journal:  Oncogene       Date:  2003-11-13       Impact factor: 9.867

10.  Expression of survivin mRNA and livin mRNA in non-small-cell lung cancer.

Authors:  Hiromi Tanabe; Atsuhito Yagihashi; Naoki Tsuji; Yasuharu Shijubo; Shosaku Abe; Naoki Watanabe
Journal:  Lung Cancer       Date:  2004-12       Impact factor: 5.705

View more
  4 in total

1.  The effects of Livin shRNA on the response to cisplatin in HepG2 cells.

Authors:  Fangfeng Liu; Hong Chang; Wei Xu; Yunpeng Zhai
Journal:  Oncol Lett       Date:  2015-08-25       Impact factor: 2.967

2.  Isolation of peptides blocking the function of anti-apoptotic Livin protein.

Authors:  Irena Crnković-Mertens; Julia Bulkescher; Christina Mensger; Felix Hoppe-Seyler; Karin Hoppe-Seyler
Journal:  Cell Mol Life Sci       Date:  2010-02-23       Impact factor: 9.261

3.  Effects of Livin gene RNA interference on apoptosis of cervical cancer HeLa cells and enhanced sensitivity to cisplatin.

Authors:  Lili Yu; Zehua Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-10-11

4.  miR-198-induced upregulation of Livin may be associated with the prognosis and contribute to the oncogenesis of lung adenocarcinoma.

Authors:  Yicheng Liang; Hetan Wang; Yuanyuan Sun; Sheng Chen; Haoyou Wang; Rong Huang; Xinyi Zhao; Weineng Fu; Chunlu Yang
Journal:  Oncol Rep       Date:  2017-08-01       Impact factor: 3.906

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.